Bill Texts: US SB1522 | 2023-2024 | 118th Congress

Bill Title: A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2023-05-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB1522 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2023-05-23PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress SB1522

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress SB1522 currently on file.

feedback